DEPRESSIVE DISORDERS IN CO-DEPENDENT PEOPLE AT DRUG ABUSE

Jenishbek B. Nazaraliev, Medical Centre of Dr. Nazaraliev

Guzel D. Adjibekova, Medical Centre of Dr. Nazaraliev

Nurlan T. Sheyitov, Medical Centre of Dr. Nazaraliev

Alevtina F. Zhelonkina, Medical Centre of Dr. Nazaraliev

Published: World Forum “Drugs, Addictions, Impacts and Responses” Book of Abstracts, Montreal, 22-27 September 2002

PROBLEM: In the last 10-15 years, it has been acknowledged that non-corrected co-dependence was an overburdening risk factor of drug abuse relapse after addict treatment completion. However, many issues are not cleared up yet in the area of co-dependence syndrome manifestations.

OBJECTIVE: To study the depressive manifestations in co-dependent people during their simultaneous hospitalization with addict.

STUDY MATERIAL: It included 130 empirically selected co-de¬pendent people from among spouses and parents of addicts, hospitalized simultaneously at MCN in 2001.

STUDY METHODS: Assess of co-dependent patient mental state, anamnestic data, original psychopathological tests, dynamic observation data, feedback questionnaires. Clinical/instrumental checkups were applied in cases of somatic complaints.

STUDY RESULTS: Out of 130 co-dependent people, 125 (96.2%) displayed depressive disorders. Mood disorder component with anxiety manifestations prevailed. Reactive depressive episodes were indicated in 58 (44.6%) patients, depressive disorders of neurotic character in 64 (49.3%), dysthymia in 37 (28.5%), neurogenous depression with obsessive-compulsive episodes in 18 (13.8%), masked depression in 9 (6.9%), and endogenous depression in 1 (0.77%) patient. 2 males (1.5%) had dipso¬mania episodes in anamnesis, 22 females (16.9%) and 8 males (6.1%) displayed unhedonia indications. Applied treatment included neuropsychopharmacological component in combina¬tion with psychotherapeutic correction of meta-image of drug abuse (MIDA)1 and co-dependence syndrome. Selective serotonin re-uptake inhibitors and tricyclic antidepressant were used in individual prescriptions, according to the character and extent of depressive disorders.

CONCLUSION: Depressive disor¬ders are obligatory (96.3%) accompanying indications in co-de¬pendence syndrome. The disclosed indications of depression make it necessary to be corrected adequately within in-patient treatment process. This is important for post-inpatient increase of addict remission quality and its duration shortening.

1. Nazaraliev 3. B. et al.. Psycho-corrective dynamics of meta-image of drug abuse in co-dependent people as a precondition for successful re-adaptation of addicted person. ICAA 44-th Conf Heidelberg 2001 Abstract Book, P. 90.